Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

NCT01273610 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms
HER2/Neu Positive
Geriatric Health Services

Interventions

DRUG: Lapatinib
DRUG: Trastuzumab
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

City of Hope Medical Center

Collaborators

[object Object]
[object Object]